Safety of non-standard regimen of systemic steroid therapy in patients with Graves' orbitopathy: a single-centre experience.

Nadia Sawicka-GutajDawid GruszczyńskiNatalia ZawalnaKacper NijakowskiAgnieszka SkibaMateusz PochylskiJerzy SowińskiMarek Ruchała

Published in: Pharmacological reports : PR (2024)

Active GO treatment with high-dose systemic GCs is not associated with serious side effects. Hyperglycemia is the most common steroid-induced complication.

Keyphrases

high dose
diabetic rats
drug induced
low dose
high glucose
oxidative stress